Red tape is strangling the bio-tech sector and its trials, everything has to be " lawyer proof " and of course patient proof as well. PD1 got the FDA green light in February with expectations to start this month and despite the clear path it takes longer. Recruiting isn't that easy due to trial specification and local circumstances like currently HerVaxx recruiting delays in India.
PTX expects to Ann's its breast cancer ph2 readings soon after 8 years since trial pH 1, B-Vaxx pH 1 started 2014 and just extended ph2, compared to that HerVaxx is a Ferrari and PD1-Vaxx might get it done even faster, maybe 3-4 years.
It all takes time despite we think " Just give them the vaxx now, can't get worse than patient dying as expected anyway" if diagnosed with stage 4.
GLTA
Prof Kaumaya - conference presentation 3 Dec, page-60
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.8¢ | 6.9¢ | 6.6¢ | $647.9K | 9.625M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 309078 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 759722 | 11 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.7¢ |
Change
0.000 ( 0.15 %) |
||||
| Open | High | Low | Volume | ||
| 6.8¢ | 6.9¢ | 6.6¢ | 3602017 | ||
| Last updated 15.57pm 31/05/2024 ? | |||||
| IMU (ASX) Chart |